A historic shift in Canadian drug policy has occurred, as the authorities permit the use of psilocybin fungi for therapeutic applications. Previously, these substances were strictly restricted, but a growing body of evidence suggests they could offer benefits for psychological illnesses like PTSD. The new policy represents a substantial step toward